Role of chemotherapy in stage IIb nasopharyngeal carcinoma

Chinese Journal of Cancer

Volumn 31, Issue 12, 2012, Pages 573-578

  Pan, Xin Bin ^a   Zhu, Xiao Dong ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Nasopharyngeal carcinoma; Stage IIb

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NONHUMAN; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; RECURRENT CANCER; TREATMENT FAILURE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FLUOROURACIL; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84871114889     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.011.10433     Document Type: Article

References (34)

1. Xiao WW, Han F, Lu TX, et al. Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma. Int J Radiat Oncol, 2009,74:1070-1076.
2. Chua DT, Sham JS, Kwong DL, et al. Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma. Cancer, 2003,98:74-80.
3. Yi JL, Gao L, Huang XD, et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int J Radiat Oncol Biol Phys, 2006,65:161-168.
4. Lee AW, Sze WM, Au JS, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys, 2005,61:1107-1116.
5. Zong JF, Ma J, Tang LL, et al. A study of the combined treatment strategy for patients with nasopharyngeal carcinoma based on the analysis of the treatment results from 749 cases. China Cancer, 2005,14:538-542. [in Chinese]
6. Teo P, Lee WY, Yu P. The prognostic significance of parapharyngeal extension in nasopharyngeal carcinoma. Radiother Oncol, 1996,39:209-221.
7. Xiao GL, Gao L, Xu GZ. Prognostic influence of para-pharyngeal space involvement in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 2002,52:957-963.
8. Chua DT, Sham JS, Kwong DL, et al. Prognostic value of parapharyngeal extension of nasopharyngeal earcinoma: a significant factor in local control and distant metastasis. Cancer, 1996,78:202-210
9. Zhang DG, Lu TX, Chen CY, et al. Prognostic significance of parapharyngeal space involvement on distant metastasis in nasopharyngeal carcinoma. Chin J Cancer Prev Treat, 2008,15: 541-543. [in Chinese]
10. Cheng SH, Tsai SY, Yen KL, et al. Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III naso-pharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 2005,61: 456-465.
11. Ho HC, Lee MS, Hsiao SH, et al. Prognostic influence of parapharyngeal extension in nasopharyngeal carcinoma. Acta Otolaryngol, 2008,128:790-798.
12. Ng WT, Chan SH, Lee AW, et al. Parapharyngeal extension of nasopharyngeal carcinoma: still a significant factor in era of modern radiotherapy? Int J Radiat Oncol Biol Phys, 2008,72: 1082-1089.
13. Ma J, Liu L, Tang L, et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res, 2007,13:1445-1452.
14. Tham IW, Hee SW, Yap SP, et al. Retropharyngeal nodal metastasis related to higher rate of distant metastasis in patients with N0 and N1 nasopharyngeal cancer. Head Neck, 2009,31:468-474.
15. O'Sullivan B. Nasopharynx cancer: therapeutic value of chemoradiotherapy. Int J Radiat Oncol Biol Phys, 2007,69: S118-S121.
16. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA I trial. Int J Radiat Oncol Biol Phys, 1996,35:463-469.
17. Chua DT, Sham JS, Choy D, et al. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Cancer, 1998,83:2270-2283.
18. Ma J, Mai HQ, Hong MH, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol, 2001,19:1350-1357.
19. Hareyama M, Sakata K, Shirato H, et al. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer, 2002,94:2217-2223.
20. Chua DT, Ma J, Sham JS, et al. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: subgroup analysis of two phase III trials. Int J Radiat Oncol Biol Phys, 2006,65: 1300-1306.
21. Song CH, Wu HG, Heo DS, et al. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma. Laryngoscope, 2008,118:663-670.
22. Yi JL, Gao L, Huang XD, et al. The outcome of stage II nasopharyngeal carcinoma treated by definitive conventional fractionation radiotherapy. Clin J Radiat Oncol, 2009,18:83-86.
23. Xu T, Hu C, Wang X, et al. Role of chemoradiotherapy in intermediate prognosis nasopharyngeal carcinoma. Oral Oncol, 2011,47:408-413.
24. Chen QY, Wen YF, Guo L, et al. Concurrent chemoradio-therapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Nat Cancer Ins, 2011,103:1761-1770.
25. Tang SG, Lin FJ, Chen MS, et al. Prognostic factors of nasopharyngeal carcinoma: a multivariate analysis. Int J Radiat Oncol Biol Phys, 1990,19:1143-1149.
26. Tang SG, See LC, Chen WC, et al. The effect of nodal status on determinants of initial treatment response and patterns of relapse-free survival in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 2000,47:867-873.
27. Wong FC, Ng AW, Lee VH, et al. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 2010,76:138-145.
28. Su SF, Han F, Zhao C, et al. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone. Int J Radiat Oncol Biol Phys, 2012,82:327-333.
29. Tham IW, Lin S, Pan J, et al. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIB nasopharyngeal cancer. Am J Clin Oncol, 2010,33:294-249.
30. Cheng SH, Tsai SY, Yen KL, et al. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma. J Clin Oncol, 2000,18:2040-2045.
31. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol, 1998,16:1310-1317.
32. Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol, 2005,23:6730-6738.
33. Lee AW, Lau WH, Tung SY, et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol, 2005,23:6966-6975.
34. Kwong DL, Sham JS, Au GK, et al. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol, 2004,22:2643-2653.